References
Hu R, Liu JX, Jiang H. Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double-blinded randomized controlled trial. J Anesth. 2012. doi:10.1007/s00540-012-1499-y.
Machata AM, Gonano C, Holzer A, Andel D, Spiss CK, Zimpfer M, Illievich UM. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg. 2003;97:904–8.
Xu YC, Xue FS, Luo MP, Yang QY, Liao X, Liu Y, Zhang YM. The median effective dose of remifentanil for awake laryngoscopy and intubation. Chin Med J. 2009;122:1507–12.
Sanchez A, Iyer RR, Morrison DE. Preparation of the patient for awake intubation. In: Hagberg CA, editor. Airway management. 2nd ed. St. Louis: Mosby-Year Book Inc; 2007. p. 256–60.
Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans: I, sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–33.
Conflict of interest
All authors have no financial support and potential conflicts of interest for this work.
Author information
Authors and Affiliations
Corresponding author
Additional information
An answer to this letter to the editor is available at doi:10.1007/s00540-013-1561-4.
About this article
Cite this article
Zhang, J.Q., Meng, F.M. & Xue, F.S. Is dexmedetomidine or remifentanil alone an optimal sedation scheme for awake intubation?. J Anesth 27, 627–628 (2013). https://doi.org/10.1007/s00540-013-1560-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-013-1560-5